← SynDRA
VOSAROXIN
SynDRA canonical compound SYN0002937 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | TOP2A |
| Mechanism of action | Topoisomerase inhibitor |
All known targets
- TOP2A
- PRKDC
- TOP2A; TOP2B
- TOP2B
Mechanisms of action (all sources)
- topoisomerase inhibitor
- TOP2A INHIBITOR
- DNA topoisomerase II inhibitor
- TOP2B INHIBITOR
- Modulator
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- Vosaroxine
- Vosaroxina
- AG-7352
- SNS-595
- SPC-595
- SNS 595
- Voreloxin
- AG 7352 (TN)
- SNS-595 (TN)
- SPC 595 (TN)
- Voreloxin (TN)
- Voreloxin (USAN)
- 1,4-Dihydro-7-(3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
- voreloxin
- AG 7352
- SPC 595
- Vosaroxin (USAN)
- Vosaroxin [USAN]
- K6A90IIZ19
- 7-((3S,4S)-3-methoxy-4-(methylamino)pyrrolidin-1-yl)-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- Quinprezo
- 7-((3S,4S)-3-methoxy-4-(methylamino)pyrrolidin-1-yl)-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid.
- trans-7-(3-Methoxy-4-(methylamino)pyrrolidin-1-yl)-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- Vosaroxin [USAN:INN]
- UNII-K6A90IIZ19
- 7-[(3S,4S)-3-methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid
- AG7352
- VOSAROXIN [INN]
- (+)-AG-7352
- VOSAROXIN [MART.]
- VOSAROXIN [WHO-DD]
- CHEMBL68117
- SCHEMBL674441
- DTXSID50938662
- EX-A847
- Voreloxin;SNS-595;AG 7352
- MFCD13185156
- NSC760764
Look up VOSAROXIN in the interactive SynDRA portal →